Last updated: March 2026
Research peptide quality is defined by three key metrics: purity percentage (98%+ is the standard), analytical method (HPLC or LCMS), and a valid Certificate of Analysis from an independent third-party lab. This guide explains how solid-phase peptide synthesis works, what these numbers actually mean, and how to verify you're not buying underdosed or contaminated product.
Solid-phase peptide synthesis is industrial chemistry — not backyard chemistry. Here's what the process actually looks like.
The gold standard for peptide manufacturing. A growing amino acid chain is built one residue at a time on a solid polymer resin. Each amino acid arrives pre-protected to prevent unintended reactions. The chain is cleaved and purified at the end. Fully automated — a single SPPS machine costs $500,000–$1M+. This is not bathtub chemistry.
Each amino acid used in synthesis arrives with chemical protecting groups on reactive side chains. These are selectively removed during synthesis to control exactly which bonds form. The quality of input amino acids is the first quality gate — reputable manufacturers source pharmaceutical-grade inputs. The chain can only be as clean as its building blocks.
After synthesis and purification, the crude peptide solution is freeze-dried to produce the white powder you receive. Lyophilization removes water without heat, preserving peptide structure. The lyophilization process also explains why heavy metal contamination is essentially non-existent in final products — the process doesn't introduce metals, and the synthesis chemistry doesn't either.
After synthesis, the raw product is run through HPLC to separate the target peptide from synthesis byproducts (deletion sequences, incomplete chains, oxidized forms). This is what drives purity from ~60–70% crude to 98%+ finished product. The quality of this step determines final purity. Complex peptides (like CJC-1295 with DAC) are harder to separate and routinely test at 90–94%.
98% purity sounds specific, but it needs context. Here's how different compounds compare — and why even pharmaceutical products aren't 100% pure.
Breaking Bad analogy: Walter White's obsession with pushing from 96% to 99% is actually chemically meaningful. The same principle applies to peptides — that 1–2% difference in impurity profile can matter for certain research applications. But 98% is the pharmaceutical industry standard. Even HGH (human growth hormone) in pharma-grade form routinely tests in the low 90s for purity by HPLC. No molecule is 100% pure in a realistic commercial batch.
Janoshik Analytical is the de facto third-party testing standard for the research peptide industry. LCMS (Liquid Chromatography-Mass Spectrometry) tests both identity and purity in a single run.
What LCMS actually does: LC separates the peptide from impurities by molecular behavior in a liquid solvent column. MS then measures the exact molecular weight of each separated component — confirming identity (does the mass match the target peptide?) and quantifying impurities (what percentage is not the target?). This is why Janoshik reports are trusted: they're measuring molecular weight, not guessing.
LCMS confirms the molecular weight of the main peak matches the target peptide. This is the primary quality gate — it proves you actually have the peptide you think you have, not something that behaves similarly in a chromatography column. Without this, purity % is meaningless.
The percentage of the sample that is the target peptide by peak area. Minor peaks are synthesis byproducts (truncated sequences, oxidized forms, deletion peptides). These impurities are typically not toxic — they're just incomplete versions of the same peptide — but high levels can reduce effective dose concentration.
Every Janoshik certificate includes a batch number, test date, and the vendor's claimed lot. This allows cross-referencing when vendors post batch test results publicly. The batch number should match the vial label — if a vendor can't provide batch-specific CoAs, they may be using a single generic certificate for multiple batches.
Heavy metal testing of lyophilized peptides detects near-zero results — essentially noise. The chemistry of SPPS doesn't introduce heavy metals. Lyophilization concentrates the peptide, not metals. For context: brown rice consistently tests above USP arsenic standards. A peptide vial typically contains less arsenic than a single serving of brown rice. This is why LCMS identity/purity testing is the substance; heavy metal panels are theater.
A legitimate CoA from Janoshik (or equivalent LCMS lab) contains specific fields. Here's what to look for and what each field means.
Quality varies dramatically across research peptide vendors. These signals help separate serious operations from low-quality or fraudulent suppliers.
Protecting peptide quality after purchase requires proper storage. These are the essentials.
Affiliate links help support MeetPeptide at no extra cost to you.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational and informational purposes only. It is not medical advice. Research peptides are NOT approved by the FDA for human therapeutic use regardless of their purity level. A 99% pure research peptide is still a research compound, not a pharmaceutical drug. Purity analysis methods and standards discussed are for informational context only. MeetPeptide does not sell peptides and makes no endorsement of specific vendors. Always consult a qualified healthcare provider before use.